Haemonetics Corporation (NYSE: HAE) has effected a 2-for-1 split of all shares of its common stock, in the form of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE